Gene Therapy, Orphan Diseases
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
10
NCT01639690
ß-Thalassemia Major with Autologous CD34+ Hematopoietic Progenitor Cells Transduced with TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2012
Completion: Jul 31, 2025
Loading map...